CYNTHIA MAGGARD: Open Payments
NPI 1659611622 · MANCHESTER, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$810 in 38 payments from 12 companies in 2025. Trend: 2023 $488 · 2024 $640 · 2025 $810
Food & beverage: $810
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 5 | $160 |
| Otsuka America Pharmaceutical, Inc. | 6 | $107 |
| ABBVIE INC. | 5 | $93 |
| Alkermes, Inc. | 4 | $81 |
| Vanda Pharmaceuticals Inc. | 3 | $67 |
| Janssen Pharmaceuticals, Inc | 3 | $62 |
| Teva Pharmaceuticals USA, Inc. | 3 | $60 |
| Lundbeck LLC | 3 | $53 |
| Indivior Inc. | 2 | $39 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $34 |
Products named: Auvelity, VRAYLAR, ABILIFY ASIMTUFII, REXULTI, SPRAVATO, UZEDY, ARISTADA, HETLIOZ.
Industry payments across KY — which companies pay providers there.
